Table 2.
Baseline characteristics of the number of MetS
| Variables | The number of the presence of MetS | |||||||
|---|---|---|---|---|---|---|---|---|
| 0 n = 52 | 1 n = 280 | 2 n = 459 | 3 n = 531 | 4 n = 286 | 5 n = 45 | P value | P < 0.05 | |
| Male, n(%) | 51 (98.0) | 251 (89.6) | 384 (83.6) | 421 (79.2) | 224 (78.3) | 38 (82.2) | <0.001 | a,b,c,d,e,f,g,h |
| Age, years | 59.3 ± 9.0 | 59.0 ± 10.6 | 59.7 ± 10.3 | 59.1 ± 9.9 | 57.6 ± 11.1 | 54.3 ± 10.3 | 0.005 | e,i,k,l,m,n |
| BMI, Kg/m2 | 24.8 ± 2.7 | 25.1 ± 2.8 | 25.8 ± 2.8 | 26.5 ± 2.9 | 28.2 ± 3.7 | 32.4 ± 2.0 | < 0.001 | b,c,d,e,f,g,h.i,j,k,l,m,n,o |
| HT, n(%) | 0 (0) | 120 (42.8) | 272 (59.2) | 388 (73.0) | 250 (87.4) | 41 (91.1) | < 0.001 | a,b,c,d,e,f,g,h,j,k,l,m,n |
| T2DM, n(%) | 0 (0) | 31 (11.0) | 136 (29.6) | 225 (42.3) | 155 (54.1) | 23 (51.1) | < 0.001 | a,b,c,d,e,f,g,h,j,k,l,m |
| Poor CC, n(%) | 4 (7.6) | 40 (14.2) | 89 (19.3) | 97 (18.2) | 102 (35.6) | 23 (51.1) | < 0.001 | d,e,h,k,m,n,o |
| SBP, mmHg | 118.2 ± 8.7 | 126.6 ± 16.3 | 127.2 ± 16.0 | 129.3 ± 16.2 | 132.3 ± 16.9 | 129.5 ± 12.8 | < 0.001 | a,b,c,d,e,g,h,j,k,m |
| DBP, mmHg | 71.0 ± 7.0 | 75.7 ± 11.3 | 75.7 ± 10.4 | 76.9 ± 11.0 | 78.4 ± 11.6 | 79.3 ± 10.4 | < 0.001 | a,b,c,d,e,h,i,k,l |
| HR, bpm | 67.3 ± 7.0 | 71.1 ± 10.5 | 72.1 ± 10.4 | 72.3 ± 9.7 | 73.0 ± 11.4 | 70.7 ± 8.1 | 0.005 | a,b,c,d,e,h |
| FBG, mmol/L | 5.1 (4.6, 5.4) | 5.2 (4.8, 5.4) | 5.4 (5.0, 6.6) | 6.2 (5.3, 8.0) | 6.9 (5.9, 8.5) | 7.6 (6.5, 9.6) | < 0.001 | b,c,d,e,f,g,h,i,j,k,l,m,n,o |
| TG, mmol/L | 1.2 (0.9, 1.3) | 1.1 (0.8, 1.3) | 1.2 (1.0, 1.6) | 1.6 (1.2, 2.3) | 2.2 (1.8, 2.9) | 2.5 (2.1, 3.9) | < 0.001 | b,c,d,e,f,g,h,i,j,k,l,m,n,o |
| GA, % | 13.8 (13.1, 15.4) | 14.1 (13.2, 15.9) | 14.3 (13.4, 16.2) | 14.7 (13.4, 17.4) | 15.8 (13.8, 19.1) | 15.9 (14.2, 19.0) | <0.001 | b,c,d,e,f,g,h,i,k,l,m |
| TC, mmol/L | 3.8 ± 0.8 | 3.9 ± 1.0 | 3.8 ± 1.1 | 3.8 ± 1.1 | 4.0 ± 1.3 | 4.2 ± 1.0 | 0.036 | k,l,m,n |
| LDL-C, mmol/L | 2.2 ± 0.8 | 2.3 ± 0.9 | 2.3 ± 1.0 | 2.2 ± 0.9 | 2.3 ± 1.0 | 2.3 ± 0.8 | 0.363 | |
| HDL-C, mmol/L | 1.2 (1.1, 1.3) | 1.2 (1.1, 1.3) | 1.0 (1.0, 1.2) | 0.9 (0.8, 1.0) | 0.9 (0.8, 1.0) | 0.9 (0.8, 1.0) | < 0.001 | b,c,d,e,f,g,h,i,j,k,l,m,n |
| LVEF, % | 54.4 ± 10.3 | 56.1 ± 8.1 | 56.0 ± 7.6 | 56.7 ± 7.4 | 56.6 ± 7.9 | 56.6 ± 7.0 | 0.419 | |
a:0vs1,b:0vs2,c:0vs3,d:0vs4,e:0vs5,f:1vs2,g:1vs3,h:1vs4,i:1vs5,g:2vs3,k:2vs4,l:2vs5,m:3vs4,n:3vs5,o:4vs5
METs Metabolic Syndrome, BMI body mass index, HT Hypertension, T2DM type 2 diabetes mellitus, CC Coronary Collateralization, SBP systolic blood pressure, DBP diastolic blood pressure, HR heart rate, FBG Fasting blood glucose, TG Triglycerides, TC Total cholesterol, LDL-C low-density lipoprotein cholesterol; HDL-C high-density lipoprotein cholesterol, GA Glycated albumin, LVEF ventricular ejection fraction